Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) EPS (Basic): 2011-2024

Historic EPS (Basic) for Abeona Therapeutics (ABEO) over the last 13 years, with Dec 2024 value amounting to -$1.55.

  • Abeona Therapeutics' EPS (Basic) rose 84.13% to -$0.10 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.59, marking a year-over-year increase of 170.98%. This contributed to the annual value of -$1.55 for FY2024, which is 38.74% up from last year.
  • Latest data reveals that Abeona Therapeutics reported EPS (Basic) of -$1.55 as of FY2024, which was up 38.74% from -$2.53 recorded in FY2023.
  • Abeona Therapeutics' EPS (Basic)'s 5-year high stood at -$0.91 during FY2020, with a 5-year trough of -$21.57 in FY2021.
  • Its 3-year average for EPS (Basic) is -$3.20, with a median of -$2.53 in 2023.
  • In the last 5 years, Abeona Therapeutics' EPS (Basic) crashed by 2,270.33% in 2021 and then spiked by 74.36% in 2022.
  • Over the past 5 years, Abeona Therapeutics' EPS (Basic) (Yearly) stood at -$0.91 in 2020, then tumbled by 2,270.33% to -$21.57 in 2021, then skyrocketed by 74.36% to -$5.53 in 2022, then soared by 54.25% to -$2.53 in 2023, then skyrocketed by 38.74% to -$1.55 in 2024.